Copeland Capital Management, LLC Amgen Inc Transaction History

Copeland Capital Management, LLC

$5.61 Billion
Q3 2024

A detailed history of Copeland Capital Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Copeland Capital Management, LLC holds 411 shares of AMGN stock, worth $114,389. This represents 0.0% of its overall portfolio holdings.

Number of Shares

411

Holding current value

$114,389

% of portfolio

0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$309.38 - $337.38 $127,155 - $138,663	411 New	411 $132,000
Q3 2021 Jan 18, 2022	BUY	$212.27 - $248.7 $87,242 - $102,215	411 New	411 $87,000
Q3 2021 Oct 20, 2021	SELL	$212.27 - $248.7 $87,242 - $102,215	-411 Closed	0 $0
Q2 2021 Jan 18, 2022	BUY	$233.58 - $259.14 $96,001 - $106,506	411 New	411 $100,000
Q2 2021 Jul 19, 2021	SELL	$233.58 - $259.14 $96,001 - $106,506	-411 Closed	0 $0
Q1 2021 Jan 18, 2022	BUY	$221.91 - $258.6 $91,205 - $106,284	411 New	411 $102,000
Q1 2021 Apr 26, 2021	SELL	$221.91 - $258.6 $91,205 - $106,284	-411 Closed	0 $0
Q4 2020 Jan 18, 2022	BUY	$216.38 - $257.67 $88,932 - $105,902	411 New	411 $94,000
Q4 2020 Jan 27, 2021	SELL	$216.38 - $257.67 $88,499 - $105,387	-409 Closed	0 $0
Q3 2020 Jan 18, 2022	BUY	$234.65 - $260.95 $95,971 - $106,728	409 New	409 $104,000
Q3 2020 Oct 22, 2020	SELL	$234.65 - $260.95 $95,971 - $106,728	-409 Closed	0 $0
Q2 2020 Jan 18, 2022	BUY	$197.81 - $242.74 $80,904 - $99,280	409 New	409 $96,000
Q2 2020 Jul 30, 2020	SELL	$197.81 - $242.74 $80,904 - $99,280	-409 Closed	0 $0
Q1 2020 Jan 18, 2022	BUY	$182.24 - $241.7 $74,536 - $98,855	409 New	409 $83,000
Q1 2020 Apr 29, 2020	SELL	$182.24 - $241.7 $74,536 - $98,855	-409 Closed	0 $0
Q4 2019 Jan 18, 2022	BUY	$189.21 - $243.2 $77,386 - $99,468	409 New	409 $99,000
Q4 2019 Feb 03, 2020	SELL	$189.21 - $243.2 $77,386 - $99,468	-409 Closed	0 $0
Q3 2019 Jan 18, 2022	BUY	$174.11 - $208.62 $71,210 - $85,325	409 New	409 $79,000
Q3 2019 Nov 06, 2019	SELL	$174.11 - $208.62 $71,210 - $85,325	-409 Closed	0 $0
Q2 2019 Jan 18, 2022	BUY	$166.7 - $195.41 $68,180 - $79,922	409 New	409 $75,000
Q2 2019 Jul 19, 2019	SELL	$166.7 - $195.41 $3.17 Million - $3.71 Million	-19,005 Closed	0 $0
Q1 2019 Jan 18, 2022	BUY	$180.87 - $203.88 $9,586 - $10,805	53 Added 0.28%	19,005 $3.61 Million
Q1 2019 Apr 24, 2019	SELL	$180.87 - $203.88 $2.62 Million - $2.95 Million	-14,477 Reduced 43.31%	18,952 $3.6 Million
Q4 2018 Jan 18, 2022	BUY	$178.4 - $208.25 $4,816 - $5,622	27 Added 0.08%	33,429 $6.51 Million
Q4 2018 Jan 28, 2019	BUY	$178.4 - $208.25 $39,604 - $46,231	222 Added 0.67%	33,402 $6.5 Million
Q3 2018 Nov 01, 2018	SELL	$185.29 - $208.89 $74,486 - $83,973	-402 Reduced 1.2%	33,180 $6.88 Million
Q2 2018 Jul 17, 2018	SELL	$166.05 - $186.51 $698,406 - $784,461	-4,206 Reduced 11.13%	33,582 $6.2 Million
Q1 2018 May 04, 2018	BUY	$169.43 - $198.0 $351,397 - $410,652	2,074 Added 5.81%	37,788 $6.44 Million
Q4 2017 Jan 30, 2018	SELL	$168.79 - $188.59 $188,200 - $210,277	-1,115 Reduced 3.03%	35,714 $6.21 Million
Q3 2017 Oct 27, 2017	BUY	$167.29 - $191.0 $6.16 Million - $7.03 Million	36,829	36,829 $6.87 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Copeland Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Copeland Capital Management, LLC with notifications on news.

Account

Copeland Capital Management, LLC Amgen Inc Transaction History